Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

OncoMed Pharmaceuticals Inc. buy melinda

Start price
€3.48
14.04.17 / 50%
Target price
€7.67
22.08.17
Performance (%)
10.88%
End price
€3.86
22.08.17
Summary
This prediction ended on 22.08.17 with a price of €3.86. The BUY prediction by melinda finished with a performance of 10.88%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
OncoMed Pharmaceuticals Inc. - - - -
iShares Core DAX® 0.611% -2.723% 14.325% 14.359%
iShares Nasdaq 100 -0.208% 6.703% 37.781% 55.710%
iShares Nikkei 225® 1.298% 1.009% 9.641% 4.825%
iShares S&P 500 0.636% 5.035% 30.827% 48.685%

Comments by melinda for this prediction

In the thread OncoMed Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 10.88%
Target price 7.667
Change
Ends at 22.08.17

es sollte funktionieren




$ 4.84
0,12 (+ 2,54%) Tarextumab - PINNACLE Studie
Lungenkrebs, kleinzelliger

OMED



Prediction Buy
Perf. (%) 10.88%
Target price 7.667
Change
Ends at 22.08.17

(Vom Mitglied beendet)

Stopped prediction by melinda for OncoMed Pharmaceuticals Inc.

buy
OncoMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.88
17.03.19
€1.13
25.04.19
-8.72%
25.04.19

buy
OncoMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.71
24.10.18
€2.16
22.01.19
-58.25%
22.01.19

buy
OncoMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.21
04.01.17
€9.02
27.02.17
25.78%
27.02.17

OncoMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€22.13
04.12.13
€19.00
04.06.14
0.00%
04.06.14